Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot P13569 (CFTR_HUMAN)

Last modified November 25, 2008. Version 130. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (8) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Cystic fibrosis transmembrane conductance regulator
      Short name=CFTR
Alternative name(s):
    cAMP-dependent chloride channel
    ATP-binding cassette transporter sub-family C member 7
Gene names
Name: CFTR
Synonyms: ABCC7
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length1480 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter.

Subunit structure

Interacts with SHANK2 By similarity. Interacts with SLC9A3R1, MYO6 and GOPC. Interacts with SLC4A7 through SLC9A3R1.

Subcellular location

Membrane; Multi-pass membrane protein.

Tissue specificity

Found on the surface of the epithelial cells that line the lungs and other organs.

Domain

The PDZ-binding motif mediates interactions with GOPC and with the SLC4A7, SLC9A3R1/EBP50 complex.

Post-translational modification

Phosphorylated; activates the channel. It is not clear whether PKC phosphorylation itself activates the channel or permits activation by phosphorylation at PKA sites.

Involvement in disease

Defects in CFTR are the cause of cystic fibrosis (CF) [MIM:219700]; also known as mucoviscidosis. CF is the most common genetic disease in the Caucasian population, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. CF is a common generalized disorder of exocrine gland function which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes.

Defects in CFTR are the cause of congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]. CBAVD is an important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens.

Sequence similarities

Belongs to the ABC transporter family. CFTR transporter (TC 3.A.1.202) subfamily. [View classification]

Contains 2 ABC transmembrane type-1 domains.

Contains 2 ABC transporter domains.

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: P13569-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: P13569-2)

The sequence of this isoform differs from the canonical sequence as follows:
     404-464: Missing.
Notes: Skipping of exon 9: a high number of TG repeats and a low number of T repeats at the intron 8-exon 9 junction favor exon skipping. Causes congenital bilateral absence of the vas deferens (CBAVD).
Isoform 3 (identifier: P13569-3)

The sequence of this isoform differs from the canonical sequence as follows:
     589-605: SCVCKLMANKTRILVTS → RRRCSCLLDRNKKTIF
     606-1480: Missing.
Notes: Skipping of the first 248 nucleotides of exon 13, caused by mutation of the exon splicing exon (ESE) in exon 13. Causes cystic fibrosis (CF).

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 14801480Cystic fibrosis transmembrane conductance regulator
PRO_0000093419

Regions

Topological domain1 – 8080Cytoplasmic Potential
Transmembrane81 – 103231 Potential
Topological domain104 – 11714Extracellular Potential
Transmembrane118 – 138212 Potential
Topological domain139 – 19456Cytoplasmic Potential
Transmembrane195 – 215213 Potential
Topological domain216 – 2205Extracellular Potential
Transmembrane221 – 241214 Potential
Topological domain242 – 30766Cytoplasmic Potential
Transmembrane308 – 328215 Potential
Topological domain329 – 3302Extracellular Potential
Transmembrane331 – 350206 Potential
Topological domain351 – 859509Cytoplasmic Potential
Transmembrane860 – 880217 Potential
Topological domain881 – 91131Extracellular Potential
Transmembrane912 – 932218 Potential
Topological domain933 – 99058Cytoplasmic Potential
Transmembrane991 – 1011219 Potential
Topological domain1012 – 10132Extracellular Potential
Transmembrane1014 – 10342110 Potential
Topological domain1035 – 110268Cytoplasmic Potential
Transmembrane1103 – 11232111 Potential
Topological domain1124 – 11285Extracellular Potential
Transmembrane1129 – 11492112 Potential
Topological domain1150 – 1480331Cytoplasmic Potential
Domain81 – 365285ABC transmembrane type-1 1
Domain423 – 646224ABC transporter 1
Domain859 – 1155297ABC transmembrane type-1 2
Domain1210 – 1443234ABC transporter 2
Nucleotide binding458 – 4658ATP 1 Potential
Nucleotide binding1244 – 12518ATP 2 Potential
Motif1478 – 14803PDZ-binding

Amino acid modifications

Modified residue5151Phosphotyrosine
Modified residue6601Phosphoserine; by PKA
Modified residue6861Phosphoserine; by PKC
Modified residue7001Phosphoserine; by PKA
Modified residue7121Phosphoserine; by PKA
Modified residue7371Phosphoserine; by PKA
Modified residue7531Phosphoserine; by PKA
Modified residue7681Phosphoserine; by PKA
Modified residue7901Phosphoserine; by PKC
Modified residue7951Phosphoserine; by PKA
Modified residue8131Phosphoserine; by PKA
Glycosylation8941N-linked (GlcNAc...)
Glycosylation9001N-linked (GlcNAc...)

Natural variations

Alternative sequence404 – 46461Missing in isoform 2.
VSP_022123
Alternative sequence589 – 60517SCVCK…ILVTS → RRRCSCLLDRNKKTIF in isoform 3.
VSP_022124
Alternative sequence606 – 1480875Missing in isoform 3.
VSP_022125
Natural variant131S → F in CF.
VAR_000101
Natural variant311R → C: dbSNP rs1800073.
VAR_000102
Natural variant311R → L in CF.
VAR_000103
Natural variant421S → F in CF.
VAR_000104
Natural variant441D → G in CF.
VAR_000105
Natural variant441D → V: dbSNP rs1800074.
VAR_000106
Natural variant501S → Y in CBAVD.
VAR_000107
Natural variant571W → G in CF.
VAR_000108
Natural variant671P → L in CF.
VAR_000109
Natural variant741R → W in CF.
VAR_000110
Natural variant751R → Q: dbSNP rs1800076.
VAR_000111
Natural variant851G → E in CF.
VAR_000112
Natural variant871F → L in CF.
VAR_000113
Natural variant911G → R in CF.
VAR_000114
Natural variant921E → K in CF.
VAR_000115
Natural variant981Q → R in CF.
VAR_000116
Natural variant1051I → S in CF.
VAR_000117
Natural variant1091Y → C in CF.
VAR_000118
Natural variant1101D → H in CF.
VAR_000119
Natural variant1111P → L in CBAVD.
VAR_000120
Natural variant1171R → C in CF.
VAR_000121
Natural variant1171R → H in CF and CBAVD.
VAR_000122
Natural variant1171R → L in CF.
VAR_000123
Natural variant1171R → P in CF.
VAR_000124
Natural variant1201A → T in CF.
VAR_000125
Natural variant1381L → P: dbSNP rs1800078.
VAR_009895
Natural variant1391H → R in CF.
VAR_000126
Natural variant1411A → D in CF.
VAR_000127
Natural variant1481I → T in CF. dbSNP rs35516286.
VAR_000128
Natural variant1491G → R in CBAVD.
VAR_000129
Natural variant1701R → H: dbSNP rs1800079.
VAR_009896
Natural variant1781G → R in CF.
VAR_000130
Natural variant1821S → G: dbSNP rs1800080.
VAR_009897
Natural variant1921Missing in CF.
VAR_000131
Natural variant1931E → K in CBAVD and CF.